Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
CEO: Adam H. Schechter. Company website
Labcorp Holdings Inc. (LH) trades at $320.71, down 0.63% on the day, as of Sep 20, 2026 13:46 UTC.
Labcorp Holdings Inc. has a market capitalisation of $26.30B, calculated from the live LH share price and shares outstanding.
LH trades at a trailing P/E of 26.53, from earnings per share of $12.09 over the last twelve months.
Labcorp Holdings Inc. generated revenue of $14.35B over the trailing twelve months, which puts the stock at 1.83 times sales.
Yes. Labcorp Holdings Inc. pays a dividend yielding 1.10% on the current share price.
LH has traded between $244.52 and $341.80 over the past 52 weeks, and the last price is 6.2% below that high.
Yes. Labcorp Holdings Inc. keeps 6.99% of revenue as net income over the trailing twelve months.
Wall Street analysts rate LH Buy, with an average price target of $337.29, 5.2% above the current price.
Labcorp Holdings Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.
Adam H. Schechter is the chief executive of Labcorp Holdings Inc., which employs 71,000 people.
QFI Terminal shows LH with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open LH in Terminal See plans